Novocure Ltd (NVCR) Event July 28, 2022, 00:00 UTC (42% Neutral) NovoCure Limited (NVCR) Reports 211% Loss Increase for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 9:05 a.m. 🏢 Novocure Ltd (NVCR) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-07-28 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-58.35M $-18.77M $-39.58M -210.89% 📈 Total Assets $1.14B $1.16B $-23.18M -1.99% ↘️ Total Liabilities $729.00M $721.00M $8.00M +1.11% ↗️ Stockholders' Equity $397.27M $-646.34M $1.04B +161.46% 📈 Operating Income/Loss $-44.33M $-12.38M $-31.95M -258.02% 📈 Gross Profit $420.15M $213.23M $206.93M +97.04% 📈 R&D Expense $201.30M $96.23M $105.07M +109.19% 📉 Revenues $535.03M $268.21M $266.82M +99.48% 📈 Earningspersharebasic $-0.56 $-0.18 $-0.38 -211.11% 📉 Earningspersharediluted $-0.56 $-0.18 $-0.38 -211.11% 📉 Costofrevenue $114.88M $54.98M $59.89M +108.93% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Novocure Ltd (NVCR) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document